Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8770311 | Journal of Renal Nutrition | 2018 | 6 Pages |
Abstract
In this sample, the modified version of the Gastrointestinal Symptom Rating Scale was a generally valid tool for measuring GI symptoms associated with a single HD treatment. Patients who ate during treatment did not experience greater GI symptoms than those who did not; however, high amounts of fat and fiber may be associated with greater GI symptoms. Prospective trials should examine the relationship between GI symptoms and dietary intake during treatment in HD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Brandon M. PhD, RD, Annabel PhD, Karen PhD, RD, Kenneth R. PhD,